Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Page

Showing results (381-390 of 422) with videos related to

Pageof 43
Sort By:
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactamsI Heinze-Krauss, P Angehrn, R L Charnas, et al.
Clinical Epigenetics|February 18, 2021
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancerKatherine A Giles, Cathryn M Gould, Joanna Achinger-Kawecka, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2011
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domainBrent D G Page, Steven Fletcher, Peibin Yue, et al.
Science Advances|March 29, 2020
Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell deathS Busker, W Qian, M Haraldsson, et al.
The Analyst|June 29, 2016
Long-term non-invasive interrogation of human dorsal root ganglion neuronal cultures on an integrated microfluidic multielectrode array platformH A Enright, S H Felix, N O Fischer, et al.
Biomaterials|November 15, 2011
An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug deliveryRajendra N Mitra, Mona Doshi, Xiaolei Zhang, et al.
EMBO Molecular Medicine|November 7, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancerJohn G Page, Baohong Tian, Karen Schweikart, et al.
Cancer Research|August 18, 2016
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-ThioguanineNicholas C K Valerie, Anna Hagenkort, Brent D G Page, et al.
Journal of Medicinal Chemistry|April 17, 2025
Challenging the "Undruggable"─Targeting STAT3 but Identifying Potent TrkA-Targeted InhibitorsPetar Iliev, Conall McCutcheon, Tizita H Admas, et al.
Pageof 43

Showing results (381-390 of 422) with videos related to

Sort By:
Pageof 43
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactamsI Heinze-Krauss, P Angehrn, R L Charnas, et al.
Clinical Epigenetics|February 18, 2021
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancerKatherine A Giles, Cathryn M Gould, Joanna Achinger-Kawecka, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2011
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domainBrent D G Page, Steven Fletcher, Peibin Yue, et al.
Science Advances|March 29, 2020
Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell deathS Busker, W Qian, M Haraldsson, et al.
The Analyst|June 29, 2016
Long-term non-invasive interrogation of human dorsal root ganglion neuronal cultures on an integrated microfluidic multielectrode array platformH A Enright, S H Felix, N O Fischer, et al.
Biomaterials|November 15, 2011
An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug deliveryRajendra N Mitra, Mona Doshi, Xiaolei Zhang, et al.
EMBO Molecular Medicine|November 7, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancerJohn G Page, Baohong Tian, Karen Schweikart, et al.
Cancer Research|August 18, 2016
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-ThioguanineNicholas C K Valerie, Anna Hagenkort, Brent D G Page, et al.
Journal of Medicinal Chemistry|April 17, 2025
Challenging the "Undruggable"─Targeting STAT3 but Identifying Potent TrkA-Targeted InhibitorsPetar Iliev, Conall McCutcheon, Tizita H Admas, et al.
Pageof 43